Siemens Holds Live Demonstrations of Groundbreaking, New Innovations in Imaging, Diagnostics and Therapy
|
By MedImaging International staff writers Posted on 04 Mar 2021 |

Illustration
Siemens Healthineers (Erlangen, Germany) highlighted its latest new innovations at the European Congress of Radiology (ECR) virtual event, March 3-10, 2021 that can help enhance access to care and leverage AI to revolutionize clinical decision making.
At the fully online ECR 2021 event held in Vienna, Austria, Siemens offered live product demonstrations of its groundbreaking, new innovations in imaging, diagnostics and therapy at its virtual ECR booth. Among its new innovations and solutions highlighted at ECR 2021 was its Magnetom Free.Max, a new class of magnetic resonance imaging (MRI) systems that the company calls “High-V MRI.” The scanner’s unique combination of digital technologies and the new field strength of 0.55 tesla broaden the range of clinical applications for MRI systems. Magnetom Free.Max considerably improves pulmonary imaging with MRI and allows patients with implants to be scanned much more accurately. Magnetom Free.Max can be installed in places where MRI used to be impossible. At just over three metric tons in weight and just below two meters in transportation height, the machine is the most lightweight as well as the most compact whole-body scanner Siemens has ever built.
Siemens also demonstrated Syngo Carbon, an all-in-one solution for easy access to all relevant data generated in the processes of imaging and reporting. Data from different departments is drawn out from various silos and integrated as part of a unified environment, including diagnostics and assessment, simplifying workflows, and making it easier for different areas to work together. Among its new innovations in molecular imaging, Siemens demonstrated Biograph Vision Quadra, a CE-Marked positron emission tomography/computed tomography (PET/CT) scanner that is designed for clinical use as well as translational research - or the application of scientific research to create therapies and procedures that improve health outcomes. In this manner, the Biograph Vision Quadra expands precision medicine.
At ECR 2021, Siemens also introduced new innovations in breast care and participated in the Breast Care Symposium where key opinion leaders in breast imaging elaborated different breast imaging modalities – from traditional breast imaging to MRI and ultrasound.
Related Links:
Siemens Healthineers
At the fully online ECR 2021 event held in Vienna, Austria, Siemens offered live product demonstrations of its groundbreaking, new innovations in imaging, diagnostics and therapy at its virtual ECR booth. Among its new innovations and solutions highlighted at ECR 2021 was its Magnetom Free.Max, a new class of magnetic resonance imaging (MRI) systems that the company calls “High-V MRI.” The scanner’s unique combination of digital technologies and the new field strength of 0.55 tesla broaden the range of clinical applications for MRI systems. Magnetom Free.Max considerably improves pulmonary imaging with MRI and allows patients with implants to be scanned much more accurately. Magnetom Free.Max can be installed in places where MRI used to be impossible. At just over three metric tons in weight and just below two meters in transportation height, the machine is the most lightweight as well as the most compact whole-body scanner Siemens has ever built.
Siemens also demonstrated Syngo Carbon, an all-in-one solution for easy access to all relevant data generated in the processes of imaging and reporting. Data from different departments is drawn out from various silos and integrated as part of a unified environment, including diagnostics and assessment, simplifying workflows, and making it easier for different areas to work together. Among its new innovations in molecular imaging, Siemens demonstrated Biograph Vision Quadra, a CE-Marked positron emission tomography/computed tomography (PET/CT) scanner that is designed for clinical use as well as translational research - or the application of scientific research to create therapies and procedures that improve health outcomes. In this manner, the Biograph Vision Quadra expands precision medicine.
At ECR 2021, Siemens also introduced new innovations in breast care and participated in the Breast Care Symposium where key opinion leaders in breast imaging elaborated different breast imaging modalities – from traditional breast imaging to MRI and ultrasound.
Related Links:
Siemens Healthineers
Latest ECR 2021 News
- GE Healthcare Showcases Innovative AI, Digital and Imaging Solutions at ECR 2021
- Hitachi Unveils MRI Systems with Human-Centered Design at ECR 2021
- Mindray Showcases Advanced Imaging and Laboratory Diagnostic Solutions at ECR 2021
- Vieworks Presents Next Generation Photon-Understanding Detector Solution Powered by AI
- First Ever Autonomous AI Medical Imaging Application Previewed at ECR 2021
- VUNO Presents State-of-the-Art AI Medical Imaging Technology at ECR 2021
- Agfa Launches Groundbreaking SmartXR Artificial Intelligence on Its Mobile DR 100s
- Canon Demonstrates How AI Can Help to Drive Workflow in COVID-19 Era
- Shimadzu Showcases Latest Lab and Imaging Technologies at ECR 2021
- Carestream Showcases New Glass-Free Detector and Intelligent Solutions for Digital Radiography at Virtual ECR 2021
- Hologic Showcases New Genius AI Powered Imaging Technology for Breast Health Care
- Philips Spotlights New and Enhanced Diagnostic and AI-Enabled Solutions to Streamline Workflows Across Imaging Enterprise
- Konica Minolta Launches New Solutions in Healthcare IT, X-Ray and Ultrasound Imaging at ECR 2021
- ECR 2021 Virtual Exhibition Features One of the Biggest-Ever Online Programs in Radiology
Channels
Radiography
view channel
Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
Obstructive ventilatory disorder, marked by airflow limitation that reduces breathing efficiency, increases postoperative risk in patients with lung cancer. Although surgery offers the best chance of cure,... Read more
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read moreMRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channelMultimodal AI Tool Combines CT and Health Records to Predict Heart Risk
Cardiovascular disease is a leading cause of death and an underrecognized risk for people treated for breast cancer. Cardiac complications can affect survival and quality of life. Clinicians need tools... Read more
AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more








